肝门部胆管癌的外科治疗策略

Surgical Treatment Strategies for Hilar Cholangiocarcinoma

肝门部胆管癌是最常见的胆道恶性肿瘤,目前根治性切除仍然是患者获得长期生存最主要的治疗方法,但其疗效至今无法令人满意,整体预后不佳。近年来,随着对该疾病临床认知、诊断和治疗策略的全面综合发展,使患者的生存期有所提高。但在胆道引流、剩余肝脏体积的处理、门静脉栓塞、手术方式的选择、肝移植等方面仍存在诸多争议。现回顾分析国内外相关文献,就以上争议问题进行综述,为改善患者预后提供参考。

Hilar cholangiocarcinoma is the most common malignant tumor of the biliary tract. At present, rad-ical resection is still the most important treatment for long-term survival of patients, but its cura-tive effect is not satisfactory so far, and the overall prognosis is poor. In recent years, with the clini-cal cognition, diagnosis and treatment strategies of the disease comprehensive development of the comprehensive, the survival of patients has improved. However, there are still many controversies in biliary drainage, management of residual liver volume, portal vein embolization, selection of sur-gical methods, and liver transplantation. This paper reviews and analyzes the relevant literature at home and abroad, and summarizes the above controversial issues, so as to provide a reference for improving the prognosis of patients.